Form 4: Alico Director Adam Putnam Reports Stock Acquisition
Insider Transaction Report
Alico, Inc. director Adam Putnam acquired 785 shares of common stock under an incentive plan.
Summary
- Adam Putnam, a Director at Alico, Inc. (ALCO), reported the acquisition of 785 shares of common stock on July 1, 2026.
- These shares were issued under the company's Amended and Restated Stock Incentive Plan of 2015.
- Following this transaction, Putnam beneficially owns 18,484 shares of Alico, Inc. common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine stock acquisition by a director under an existing plan, with no significant new information or strategic shifts disclosed.
Positives
- Director acquisition of company stock can signal confidence in the company's future prospects.
- The acquisition of 785 shares by a director indicates continued alignment with shareholder interests.
Future Outlook
No specific forward-looking statements or guidance were provided in this filing.
Industry Context
StockSavvy.ai notes that insider stock acquisitions, particularly by directors, are common in the agricultural and land management sectors as a signal of commitment and belief in long-term value.
Stakeholder Impact
- Shareholders: The acquisition by a director may be viewed positively as a sign of confidence in the company's performance and future prospects.
Key Dates
| Date | Description |
|---|---|
| 07/01/2026 | Transaction Date for stock acquisition |
| 07/02/2026 | Date of filing signature |
Keywords
Alico Inc, ALCO, Form 4, Insider Trading, Stock Incentive Plan, Director, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.